Cannabinoid Receptors: Where They are and What They do
- 17 April 2008
- journal article
- review article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 20 (s1), 10-14
- https://doi.org/10.1111/j.1365-2826.2008.01671.x
Abstract
The endocannabinoid system consists of the endogenous cannabinoids (endocannabinoids), cannabinoid receptors and the enzymes that synthesise and degrade endocannabinoids. Many of the effects of cannabinoids and endocannabinoids are mediated by two G protein-coupled receptors (GPCRs), CB(1) and CB(2), although additional receptors may be involved. CB(1) receptors are present in very high levels in several brain regions and in lower amounts in a more widespread fashion. These receptors mediate many of the psychoactive effects of cannabinoids. CB(2) receptors have a more restricted distribution, being found in a number of immune cells and in a few neurones. Both CB(1) and CB(2) couple primarily to inhibitory G proteins and are subject to the same pharmacological influences as other GPCRs. Thus, partial agonism, functional selectivity and inverse agonism all play important roles in determining the cellular response to specific cannabinoid receptor ligands.Keywords
This publication has 42 references indexed in Scilit:
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The complications of promiscuity: endocannabinoid action and metabolismBritish Journal of Pharmacology, 2007
- A biosynthetic pathway for anandamideProceedings of the National Academy of Sciences of the United States of America, 2006
- Targeted lipidomics: Discovery of new fatty acyl amidesThe AAPS Journal, 2006
- In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor?British Journal of Pharmacology, 2006
- Cannabinoids, electrophysiology, and retrograde messengers: Challenges for the next 5 yearsThe AAPS Journal, 2006
- Molecular Composition of the Endocannabinoid System at Glutamatergic SynapsesJournal of Neuroscience, 2006
- Inactivation of N-Acyl Phosphatidylethanolamine Phospholipase D Reveals Multiple Mechanisms for the Biosynthesis of EndocannabinoidsBiochemistry, 2006
- Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 ReceptorsThe Journal of pharmacology and experimental therapeutics, 2005
- Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonistBritish Journal of Pharmacology, 2004